Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
$0.28
$-0.11
(-27.69%)
As on 25-Nov-2025 09:30EDT
Market cap
$13 Mln
Revenue (TTM)
$315 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-169 Mln
-
ROE
-7.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
15.5
-
Debt to Equity
0
-
Book Value
$0
-
EPS
$0
-
Face value
--
-
Shares outstanding
33,874,403
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
| -95.6 | -27.7 | -48.3 | -- | -- | -- | -- |
|
BSE Sensex*
| -9.9 | -3.3 | 2.8 | -5.4 | 5.0 | 5.5 | 10.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic... skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd. Read more
-
CEO & Chairman of the Board
Ms. Xiaoqiu Zhang
-
CEO & Chairman of the Board
Ms. Xiaoqiu Zhang
-
Headquarters
Wuxi
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
What is the current share price of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) Today?
The share price of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) is $0.28 (NASDAQ) as of 25-Nov-2025 09:30 EDT. Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH)?
Since, TTM earnings of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
429.87 |
136.59 |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
2017 |
-- |
-- |
What is the 52 Week High and Low of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH)?
The 52-week high and low of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) are Rs 41.37 and Rs 0.25 as of 07-Sep-2026.
What is the market cap of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH)?
Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) has a market capitalisation of $ 13 Mln as on 25-Nov-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH)?
Before investing in Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.